Hints and tips:
Related Special Reports
...Pfizer has been the biggest drag on the S&P 500 this year, and on Wednesday hit its lowest level since 2013....
...Haleon declined to comment on Pfizer’s plans....
...And finally To the V&A in London, where a new blockbuster exhibition, Gabrielle Chanel: Fashion Manifesto, highlights both the designer’s revolutionary approach and her many links with Britain....
...Nicholas Malins-Smith Cambridge, UK...
...In 1738, the statue of Handel as Orpheus, now in the V&A, was unveiled at Vauxhall’s Spring Gardens in London....
...Additional reporting by Nicholas Megaw in New York...
...Given that close to three-quarters of the 224mn vaccine doses administered in Germany were produced by BioNTech in collaboration with Pfizer, the vast majority of the claims are being brought against the...
...“The previous bear market was such a ‘V’. [Stocks] went down and came roaring back,” he said. “I think this one is going to exhaust people.” Additional reporting by Jennifer Hughes in New York...
...Arrival is merging with Kensington Capital Acquisition Corp V, paying a huge premium in order to add $300mn to its balance sheet. It is a desperate move that is unlikely to trigger a Spac revival....
...Alongside Smith, outdoor pursuits are headed-up by 29-year-old Nicholas Raby, a former gamekeeper who — in Gleneagles’ eyes — embodies the future of shooting sports....
...After Hodgkin’s death in 2017, Peattie hoped to follow in their footsteps, and sought advice from former Tate director Nicholas Serota. “He advised strongly against it,” he says with a sigh....
...Sidley Austin has hired Kirkland & Ellis’ Nicholas Cassin as partner in its investment funds practice, based in New York....
...The crypto investment platform run by Emerson Pires, Flavio Goncalves and Joshua David Nicholas was, you guessed it, a suspected Ponzi scheme....
...Pfizer, one of the developers of the most widely used Covid-19 vaccines, added on Wednesday that early studies showed a third shot of the BioNTech/Pfizer vaccine offered protection against Omicron, but two...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...by what Sean Darby, Jefferies strategist, described as “a shower of good news” over the past week, including stronger than expected data on the US jobs market, positive results from late-stage trials of Pfizer...
...“An offset V-peak lapel, a signature shape first created by the legendary Huntsman head cutter Colin Hammick, cheats the eye and makes the wearer look well proportioned, and even athletic.”...
...Pfizer didn’t fall as much because of its wider array of products....
...As ever, reach out to Imani (imani.moise@ft.com) or me (sid.v@ft.com) with your thoughts and suggestions. And if you haven’t already, please sign up to the FT’s new Cryptofinance newsletter here....
...Coronavirus vaccine supplies to the Philippines expected this week have been delayed, officials said at the weekend, as the country signed a deal with Pfizer/BioNTech to provide 40m jabs....
...Mexico has also received deliveries of the Sinovac Biotech, Pfizer/BioNTech, AstraZeneca and CanSino jabs....
International Edition